Jpmorgan Chase & CO Pacific Biosciences Of California, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 514,505 shares of PACB stock, worth $761,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
514,505
Previous 564,507
8.86%
Holding current value
$761,467
Previous $959,000
1.88%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding PACB
# of Institutions
261Shares Held
225MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36MShares$53.3 Million0.58% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$34.9 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$34.6 Million8.16% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.3MShares$31.6 Million0.68% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$30.3 Million0.17% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $333M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...